Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page
- Check4 days agoChange DetectedThe page now states 'No longer looking for participants' and adds sections to help readers interpret the study record ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). The heading for the Intervention/Treatment section was standardized (Intervention / Treatment removed) and the page revision updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check11 days agoChange DetectedThe revision label on the page has been updated from v3.5.4 to v3.5.5. This indicates a minor update to the page rather than a change to its content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page version was updated from v3.5.3 to v3.5.4, signaling a maintenance release that does not alter the study details displayed on the page.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s interface/version label was updated from **Revision v3.5.2** to **Revision v3.5.3**.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check82 days agoChange DetectedReplaced Napoli, Italy, 80138 with Naples, Italy, 80138 to standardize the study site location naming.SummaryDifference0.0%

Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.